EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer

Yi Sia, Radu Mihai iD

Cancers · 25.03.2026 · 18 (7) · 1058

DOI: 10.3390/cancers18071058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 25.03.2026. Verfasst von Yi Sia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Surgery, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is ongoing interest in limiting the extent of treatment for patients with low-risk differentiated thyroid cancer (DTC) and in redesigning individualised follow-up strategies. This study assessed long-term outcomes in patients with excellent response to surgical treatment demonstrated by reaching unmeasurable stimulated thyroglobulin (sTG) levels before proceeding with radioactive iodine ablation.

Methods

This is a retrospective cohort study of consecutive patients treated for DTC in a tertiary referral centre. Radioactive iodine ablation (RIA) was done after hormone withdrawal (before 2015) or after Thyrogen stimulation (in recent years). The biochemical assay for TG changed from a lower limit of detectability of 5 ng/mL to 0.2 ng/mL in 2012.

Results

Of 331 patients operated on between 2001 and 2019, unmeasurable sTG was measured in 70 of 138 patients (51%) when using an assay with threshold of 5 ng/mL and in 38 of 193 patients (20%) based on the threshold of 0.2 ng/mL. Compared with patients whose sTG was >5 ng/mL, those with sTG

Schlagwörter

Stichwörter der Autor:innen

recurrencethyroglobulinthyroid cancer

Autor:innen und Institutionen

  • Department of Endocrine Surgery, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.

ORCID-Profile: Radu Mihai

Zitieren

APA

Sia, Y., & Mihai, R. (2026). Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer. Cancers, 18(7), 1058. https://doi.org/10.3390/cancers18071058

Vancouver

Sia Y, Mihai R. Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer. Cancers. 2026;18(7):1058. doi:10.3390/cancers18071058

BibTeX
@article{Sia2026,
  author = {Sia, Yi and Mihai, Radu},
  title = {Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1058},
  doi = {10.3390/cancers18071058}
}
Kostenlos starten →